Sonova Holding (OTCMKTS:SONVY) Short Interest Up 3,416.8% in May

Sonova Holding (OTCMKTS:SONVYGet Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totaling 72,798 shares, a growth of 3,416.8% from the April 30th total of 2,070 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 84,663 shares, the short-interest ratio is currently 0.9 days.

Analyst Upgrades and Downgrades

SONVY has been the topic of several analyst reports. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Citigroup restated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Finally, Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

View Our Latest Analysis on Sonova

Sonova Stock Performance

OTCMKTS:SONVY traded up $0.48 during trading hours on Friday, reaching $53.03. The company had a trading volume of 18,038 shares, compared to its average volume of 40,348. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The business’s 50-day simple moving average is $46.48 and its two-hundred day simple moving average is $49.92. Sonova has a twelve month low of $42.26 and a twelve month high of $63.69.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Articles

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.